Publications

2023

Adegbite BO, Abramson MH, Gutgarts V, Musteata MF, Chauhan K, Muwonge AN, et al. Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics. medRxiv. 2023.
González-Muñoz T, Di Giannatale A, García-Silva S, Santos V, Sánchez-Redondo S, Savini C, et al. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Clin Cancer Res. 2023;29(18):3744-3758.
Setton J, Hadi K, Choo Z-, Kuchin KS, Tian H, Paula AD, et al. Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature. 2023;621(7977):129-137.
Girardi NI, Cushing MM, Evered LA, Benedetto U, Schwann TA, Kurlansky P, et al. Incidence and Impact of a Single-Unit Red Blood Cell Transfusion: Analysis of The Society of Thoracic Surgeons Database 2010-2019. Ann Thorac Surg. 2023;115(4):1035-1041.
Ma C, Wang X, Dai JY, Turman C, Kraft P, Stopsack KH, et al. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiol Biomarkers Prev. 2023;32(10):1436-1443.
Cheong J-, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186(18):3882-3902.e24.
Magahis PT, Westerveld D, Simons M, Hissong E, Carr-Locke DL, Sampath K, et al. EUS-guided liver biopsy using a novel hydrostatic stylet technique. VideoGIE. 2023;8(3):104-106.
Sloan SL, Brown F, Long M, Weigel C, Koirala S, Chung J-, et al. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. Blood. 2023;142(10):887-902.
Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.
Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, et al. Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Arch Pathol Lab Med. 2023;147(10):1148-1157.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700